Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome.
Baraniuk, James N, Eaton-Fitch, Natalie, Marshall-Gradisnik, Sonya · Frontiers in immunology · 2024 · DOI
Quick Summary
Researchers combined results from 28 previous studies to confirm that people with ME/CFS have natural killer (NK) cells—a type of immune cell that fights infections and abnormal cells—that work at about half the strength of healthy people's NK cells. This is one of the most reliable biological differences found in ME/CFS. The analysis confirms this is a real, consistent problem in the condition.
Why It Matters
NK cell dysfunction is the most consistent immune abnormality identified in ME/CFS research, and quantifying its magnitude across multiple studies strengthens the biological basis of the condition. This meta-analysis provides reliable evidence that could guide development of immune-targeted therapies and validate NK cell assessment as a potential biomarker for ME/CFS diagnosis and disease progression.
Observed Findings
NK cell cytotoxicity in ME/CFS patients is reduced to approximately 50% of healthy control levels
Overall effect size (Hedges' g) was 0.96 with 95% confidence interval 0.75–1.18
28 published papers were identified; 55 E:T ratio data points were analyzed
Heterogeneity in results was explained partially by variations in E:T ratios, methodological approaches, and potential outlier studies
NK cell dysfunction shows reproducibility across multiple independent research studies
Inferred Conclusions
Reduced NK cell cytotoxicity is a consistent and measurable immune abnormality in ME/CFS
The magnitude of NK cell dysfunction (approximately 50% of control levels) is substantial and likely biologically significant
NK cell dysfunction warrants further investigation as a potential pathomechanistic mechanism and biomarker in ME/CFS
Standardization of methods and E:T ratios may reduce heterogeneity in future NK cell research
Remaining Questions
Does NK cell dysfunction directly cause ME/CFS symptoms, or is it a secondary consequence of the disease process?
What This Study Does Not Prove
This study does not prove that reduced NK cell function causes ME/CFS or is responsible for specific ME/CFS symptoms—it only confirms the association exists. The meta-analysis cannot establish whether NK cell dysfunction precedes disease onset, develops as a consequence of illness, or contributes to post-exertional malaise or other cardinal features. It also does not clarify whether restoring NK cell function would improve clinical outcomes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →